Metabolic Outcomes in a Randomized Trial of Nucleoside, Nonnucleoside and Protease Inhibitor-Sparing Regimens for Initial HIV Treatment

2009

Background The metabolic effects of initial therapy for HIV-1 infection are important determinants of regimen selection.

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

28

References

223

Citations